MedWatch Delivers Unmatched Savings on Dialysis Claim Repricing Services!
Lake Mary, FL – Continuing their dedication to delivering high-quality and low-cost solutions that benefit employer driven health plans, MedWatch once again leads the industry with their comprehensive Dialysis Claim Savings Solution delivering fully defensible repriced dialysis claims at savings averaging 91% off of billed charges, and at a low flat rate fee.
“It is not widely known that a plan often has the ability to carve out dialysis claims and reprice them with a more effective solution that will deliver greater savings at reduced costs.” stated Tim Guzinski, SVP of Marketing & Business Development with MedWatch. “At MedWatch, we understand the importance of a Plan Sponsor’s fiduciary responsibility, and therefore want to help them find every possible option to improve the care delivered to plan members while reducing costs that impact both the members’ and the plan’s financial assets.”
Dialysis charges are notoriously high dollar claims expenses for a plan. Thus, they present an opportunity for large savings when the correct solution provider is involved. However, part of the plan’s fiduciary responsibility is to make sure that they are managing the plan’s assets appropriately. The question must be raised, ‘is the plan meeting this requirement if they choose a vendor that charges them a percent of savings as a fee?’ Sometimes the percentage of savings fee paid to the service provider is actually more than the payment to the provider! Plans should also be wary of case rate fee schedules that do not disclose what the actual vendor compensation is.
MedWatch’s proven process is highly detailed and includes the clinical review, repricing and defending of the claim – for the life of the claim – and is invoiced at a fully transparent, minimal flat fee per program participant per month.
Implementing a dialysis repricing solution is necessary to help manage the plan assets, but this process is at the back end of a much bigger issue – identifying potential plan members who have or are trending towards Chronic Kidney Disease (CKD) and working with patients who have End Stage Renal Disease (ESRD). MedWatch’s URAC Accredited Disease Management and Case Management programs provide expertise in effectively identifying and engaging these members whereby the process of education and condition management can begin, helping CKD patients to slow or stop the progression of their condition(s) before they need dialysis treatment, and help coordinate the necessary processes, dialysis treatments and transplant coordination, for ESRD patients.
As part of these exceptional services, MedWatch communicates the importance of Medicare Parts A & B to the member and why they would benefit from following through and getting enrolled. This is just another example of MedWatch’s commitment to ongoing member support and advocacy.
Contact MedWatch directly to learn more about how they can immediately impact the financial bottom line for your health plan with their Dialysis Repricing and Kidney Care programs, as well as their comprehensive suite of population health care management solutions.
PH: 321.249.9179 Email: Sales@urmedwatch.com Web: urMedWatch.com
—
About MedWatch
With over 36 years of experience, MedWatch continues to lead the industry with comprehensive medical management and cost containment solutions that provide positive impacts in delivering quality care at significant savings. URAC Accredited in Health Utilization Management, Case Management, and Disease Management, MedWatch offers a cohesive suite of services that work seamlessly together providing administrators and plans a single source vendor partner that can help minimize the integration process while simplifying the member experience – all while achieving improved clinical and financial outcomes.